Jiangsu Jibeier Pharmaceutical Co.,Ltd.’s Net Profit Rose 4.1% in First Three Quarters of 2022

Jiangsu Jibeier Pharmaceutical Co.,Ltd. (江苏吉贝尔药业股份有限公司) (688566.SH) reported a net profit of 78.9 million yuan in the first three quarters of 2022, up 4.1% year-on-year.

Meanwhile, the company posted 426.6 million yuan in revenue, up 16.3% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 269.9 million yuan in total liabilities, with a liability-to-asset ratio of 14.3%.